Syngene International DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.77×	0.75×	0.82×	0.78×
	0.84×	0.88×	1.08×	1.05×	1.05×
	8.6%	12.5%	16.7%	16.9%	17.8%
	0.54×	0.54×	0.56×	0.58×	0.56×
	1.37×	1.46×	1.44×	1.44×	1.61×
	3.9%	6.7%	11.0%	12.3%	13.1%
	6.6%	6.6%	11.1%	13.0%	13.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SYNGENE₹398.60

Syngene International Ltd.

· Pharma & Health

₹ CrorePeersSAILIFE DIVISLAB WOCKPHARMA GLAND ASTERDM PPLPHARMA COHANCE LALPATHLABMcap ₹16,060 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.78	0.82	0.75	0.77	0.74
Interest Burden (Pretax/EBIT) ×	1.05	1.05	1.08	0.88	0.84
EBIT Margin %	17.79	16.87	16.73	12.45	8.57
Asset Turnover ×	0.56	0.58	0.56	0.54	0.54
Financial Leverage (Assets/Equity) ×	1.61	1.44	1.44	1.46	1.37
ROE (5-step product, year-end total equity) %	13.13	12.25	10.97	6.67	3.91
ROE (owners' profit / average owners' equity) %	13.43	12.95	11.05	6.62	6.62

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.